Effect of recombinant aprotinin on postoperative blood loss and coronary vascular function in a canine model of cardiopulmonary bypass.

@article{Veres2007EffectOR,
  title={Effect of recombinant aprotinin on postoperative blood loss and coronary vascular function in a canine model of cardiopulmonary bypass.},
  author={G{\'a}bor Veres and Tam{\'a}s Radovits and Holger Schultz and Li-ni Lin and Joachim H{\"u}tter and Ernst Weigang and Zolt{\'a}n Szabolcs and G{\'a}bor Szab{\'o}},
  journal={European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery},
  year={2007},
  volume={32 2},
  pages={
          340-5
        }
}
  • G. Veres, T. Radovits, G. Szabó
  • Published 1 August 2007
  • Medicine, Biology
  • European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
View on PubMed
academic.oup.com
6 Citations
Background Citations
1

Figures and Tables from this paper

6 Citations

Citation Type

Citation Type

Effects of novel synthetic serine protease inhibitors on postoperative blood loss, coagulation parameters, and vascular relaxation after cardiac surgery.
Pharmacological Activation of Soluble Guanylate Cyclase Protects the Heart Against Ischemic Injury
TLDR
Results show that cinaciguat treatment improves histopathological lesions, improves cardiac performance, improves impaired cardiac relaxation, reduces oxidative stress, ameliorates intracellular enzyme release, and decreases cyclooxygenase 2, transforming growth factor-β, and β-actin mRNA expression in experimentally induced myocardial infarction in rats.
Managing the inflammatory response after cardiopulmonary bypass: review of the studies in animal models
  • G. Liguori, A. Kanas, L. Moreira
  • Medicine, Biology
    Revista brasileira de cirurgia cardiovascular : orgao oficial da Sociedade Brasileira de Cirurgia Cardiovascular
  • 2014
TLDR
Demonstrated efficacy in animal models establishes a perspective for evaluating therapeutic interventions to inflammatory response and microcirculatory changes after cardiopulmonary bypass in clinical practice.
Hämostyptika
Zusammenfassung Desmopressin (DDAVP) wurde 1966 als Abkömmling des antidiuretischen Hypophysenhormons Arginin-Vasopressin synthetisch hergestellt. Zu den antidiuretischen Indikationen zählen Diabetes…
Fibrinolysis and Antifibrinolytics
[Novel antioxidant therapeutic strategies for cardiovascular dysfunction associated with ageing].
TLDR
The results demonstrate the importance of endogenous peroxynitrite-overproduction and the activation of the PARP pathway in the age-related functional decline of the cardiovascular system and highlight the need for novel antioxidant therapeutic utilities to improve ageing-associated cardiovascular dysfunction.

References

SHOWING 1-10 OF 22 REFERENCES
Effect of aprotinin on vascular reactivity of coronary bypass grafts.
Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass.
Effects of aprotinin on endothelium-dependent relaxation of large coronary arteries.
  • J. Fischer, M. Steinhoff
  • Medicine, Biology
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
  • 2005
Effect of aprotinin (Trasylol) on aorta-coronary bypass graft patency.
Aprotinin impairs coronary endothelial function and down-regulates endothelial NOS in rat coronary microvascular endothelial cells.
Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations.
Reduction of myocardial reperfusion injury by aprotinin after regional ischemia and cardioplegic arrest.
Aprotinin for primary coronary artery bypass grafting: a multicenter trial of three dose regimens.
Aprotinin impairs endothelium-dependent relaxation in rat aorta and inhibits nitric oxide release from rat coronary endothelial cells.
Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial.
...
1
2
3
...